These trials completed more than 12 months ago and should have reported results.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Listed as ongoing, but also has a completion date and reported results 2016-000460-42 A Phase 2, Randomized, Double-Blind, Placebo Controlled, Study to Evaluate Multiple Doses of AK001 in Patients With Moderate to Severe Nasal Polyposis 2018-01-05 bad-data
Ongoing 2017-002581-51 An Open-Label, Pilot Study to Assess the Efficacy and Safety Of AK002 (Siglec-8) in Patients with Antihistamine-Resistant Chronic Urticaria not-yet-due
Exempt 2018-000165-36 A Phase 1b, Open-Label, Multiple-Dose, Proof-of-Concept Study to Evaluate the Safety, Tolerability, Pharmacodynamics and Efficacy of AK002 in Patients with Peanut Allergy not-yet-due